irinotecan has been researched along with fotemustine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnard, V; Bonnet, PA; Bressolle, F; Deleuze-Masquefa, C; Gayraud-Paniagua, S; Moarbess, G; Pinguet, F; Vidal, JR | 1 |
| Grant, SC; Kris, MG | 1 |
| Beige, A; Borsotti, F; Farah, W; Ghiringhelli, F; Ilie, SM; Lecuelle, J; Mazilu, I; Truc, G; Truntzer, C; Vincent, J | 1 |
1 review(s) available for irinotecan and fotemustine
| Article | Year |
|---|---|
New antineoplastic agents in lung cancer 1988-1993.
Topics: Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Humans; Irinotecan; Lung Neoplasms; Nitrosourea Compounds; Organophosphorus Compounds; Paclitaxel; Teniposide; Vinblastine; Vinorelbine | 1995 |
2 other study(ies) available for irinotecan and fotemustine
| Article | Year |
|---|---|
In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Databases, Factual; Female; Humans; Imidazoles; Mice; Mice, Nude; Molecular Structure; Pyrazoles; Quinoxalines; Xenograft Model Antitumor Assays | 2008 |
Efficacy of Chemotherapy Plus Bevacizumab in Recurrent Glioblastoma Multiform: A Real-life Study.
Topics: Bevacizumab; Chronic Disease; Cytotoxins; Glioblastoma; Humans; Irinotecan; Recurrence; Retrospective Studies; Temozolomide | 2022 |